Nutritional status in girls with juvenile chronic arthritis

Human Nutrition. Clinical Nutrition
|January 1, 1986
PubMed

Insights

Juvenile chronic arthritis (JCA) in girls is linked to lower selenium and impaired growth. Nutritional status changes, including reduced muscle mass, were more severe with higher disease activity.

Area of Science:

  • Pediatric Rheumatology
  • Nutritional Science
  • Immunology

Background:

  • Juvenile chronic arthritis (JCA) is an inflammatory condition affecting children.
  • Nutritional status, particularly micronutrients involved in inflammation, may be altered in JCA.
  • Understanding these alterations is crucial for managing disease progression and growth.

Purpose of the Study:

  • To investigate the nutritional status of girls with JCA, focusing on key nutrients.
  • To assess the relationship between nutritional status and disease activity in JCA.
  • To evaluate growth parameters and muscle mass in JCA patients.

Main Methods:

  • Compared nutritional markers (selenium, glutathione peroxidase, ascorbic acid, tocopherol, folate, cobalamin) in 26 JCA girls and healthy controls.
  • Assessed plasma, blood, platelet, mononuclear cell, and granulocyte nutrient levels.
  • Measured growth parameters, serum creatinine, and arm muscle circumference.

Main Results:

  • JCA patients showed decreased plasma selenium and slightly depressed blood glutathione peroxidase activity, more pronounced with higher disease activity.
  • A slight decrease in granulocyte ascorbic acid was noted in JCA patients.
  • Arthritic patients exhibited impaired growth, lower serum creatinine, and reduced arm muscle circumference, particularly in systemic or polyarticular JCA.

Conclusions:

  • JCA is associated with specific nutritional deficiencies and reduced muscle mass.
  • Disease activity correlates with the severity of certain nutritional and physical changes.
  • Dietary supplementation may help correct these nutritional deficits, warranting further research.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...